Related Experiment Video
Updated: Jul 17, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Prostate specific antigen velocity threshold for predicting prostate cancer in young men
Stacy Loeb1, Kimberly A Roehl, William J Catalona
1Department of Urology, Georgetown University School of Medicine, Washington, DC, USA.
The Journal of Urology
|February 14, 2007
Summary
A lower prostate specific antigen (PSA) velocity threshold of 0.4 ng/ml yearly is more effective for detecting prostate cancer in men under 60. This revised threshold improves early detection in younger men, unlike the traditional 0.75 ng/ml cutoff.
Area of Science:
- Urology
- Oncology
- Biomarker Research
Background:
- Prostate specific antigen (PSA) velocity is crucial for guiding prostate biopsy recommendations.
- A PSA velocity threshold of 0.75 ng/ml/year is commonly used but may be too high for younger men.
- Younger men with lower baseline PSA levels may benefit from a more sensitive PSA velocity threshold.
Purpose of the Study:
- To evaluate the optimal prostate specific antigen (PSA) velocity threshold for prostate cancer detection in men aged 60 years or younger.
- To determine if PSA velocity is an independent predictor of prostate cancer in this demographic.
- To assess the efficacy of a lower PSA velocity threshold compared to the established 0.75 ng/ml/year cutoff.
Main Methods:
- Analysis of data from a large prostate cancer screening study involving 6,844 men aged 60 or younger.
- Calculation of prostate specific antigen (PSA) velocity for eligible participants.
- Multivariate analysis to assess PSA velocity's predictive value for prostate cancer risk, including subgroup analysis for men with low total PSA.
Main Results:
- Men diagnosed with prostate cancer had a significantly higher median PSA velocity (0.840 ng/ml/year) compared to those without cancer (0.094 ng/ml/year).
- A PSA velocity threshold of 0.4 ng/ml/year was a stronger independent predictor of prostate cancer than age, total PSA, family history, or race in men under 60.
- In young men, a PSA velocity cutoff of 0.4 ng/ml/year demonstrated 67.3% sensitivity and 81.2% specificity for prostate cancer detection.
Conclusions:
- The established prostate specific antigen (PSA) velocity threshold of 0.75 ng/ml/year is inadequate for men under 60, potentially missing 48% of prostate cancers.
- A PSA velocity threshold of 0.4 ng/ml/year is recommended for identifying young men at increased risk of prostate cancer.
- Close monitoring and follow-up are warranted for younger men exhibiting a PSA velocity exceeding 0.4 ng/ml/year.
Related Concept Videos
01:13Sensitivity, Specificity, and Predicted Value
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...